Q2 2025 Earnings Forecast for Patterson Companies, Inc. (NASDAQ:PDCO) Issued By William Blair

Patterson Companies, Inc. (NASDAQ:PDCO) – William Blair decreased their Q2 2025 earnings per share estimates for shares of Patterson Companies in a research note issued to investors on Wednesday, August 28th. William Blair analyst B. Vazquez now expects that the company will earn $0.49 per share for the quarter, down from their prior estimate of $0.51. The consensus estimate for Patterson Companies’ current full-year earnings is $2.36 per share. William Blair also issued estimates for Patterson Companies’ Q3 2025 earnings at $0.66 EPS, Q4 2025 earnings at $0.96 EPS, FY2025 earnings at $2.35 EPS and FY2026 earnings at $2.52 EPS.

Several other equities analysts have also weighed in on the stock. Bank of America decreased their target price on shares of Patterson Companies from $31.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday. JPMorgan Chase & Co. lowered their price objective on Patterson Companies from $29.00 to $26.00 and set a “neutral” rating for the company in a research report on Thursday. Evercore ISI cut their target price on Patterson Companies from $25.00 to $23.00 and set an “in-line” rating for the company in a research note on Thursday. Morgan Stanley decreased their price target on Patterson Companies from $30.00 to $28.00 and set an “equal weight” rating on the stock in a research note on Thursday, June 20th. Finally, StockNews.com downgraded Patterson Companies from a “buy” rating to a “hold” rating in a research report on Saturday, June 1st. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Patterson Companies currently has a consensus rating of “Hold” and an average price target of $28.89.

Patterson Companies Stock Up 0.1 %

NASDAQ PDCO opened at $22.49 on Friday. The company has a quick ratio of 0.75, a current ratio of 1.33 and a debt-to-equity ratio of 0.33. Patterson Companies has a 52 week low of $21.56 and a 52 week high of $32.58. The business’s fifty day simple moving average is $24.53 and its 200-day simple moving average is $25.47. The firm has a market cap of $1.97 billion, a PE ratio of 11.25, a P/E/G ratio of 2.32 and a beta of 1.06.

Patterson Companies (NASDAQ:PDCO) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.08). Patterson Companies had a net margin of 2.83% and a return on equity of 20.80%. The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the company posted $0.40 earnings per share. The firm’s revenue for the quarter was down 2.3% compared to the same quarter last year.

Institutional Trading of Patterson Companies

Large investors have recently made changes to their positions in the stock. GAMMA Investing LLC acquired a new stake in shares of Patterson Companies during the fourth quarter worth $32,000. LRI Investments LLC increased its stake in shares of Patterson Companies by 201.2% during the 2nd quarter. LRI Investments LLC now owns 1,262 shares of the company’s stock valued at $30,000 after acquiring an additional 843 shares during the last quarter. Spire Wealth Management purchased a new position in shares of Patterson Companies during the 1st quarter worth about $35,000. Mather Group LLC. grew its holdings in Patterson Companies by 1,376.1% in the second quarter. Mather Group LLC. now owns 1,609 shares of the company’s stock valued at $39,000 after purchasing an additional 1,500 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new position in Patterson Companies during the second quarter worth approximately $41,000. Institutional investors and hedge funds own 85.43% of the company’s stock.

Insider Activity

In related news, CEO Donald Zurbay sold 7,216 shares of Patterson Companies stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $24.99, for a total value of $180,327.84. Following the transaction, the chief executive officer now directly owns 230,072 shares in the company, valued at approximately $5,749,499.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Donald Zurbay sold 7,216 shares of the company’s stock in a transaction on Tuesday, July 16th. The stock was sold at an average price of $24.99, for a total transaction of $180,327.84. Following the transaction, the chief executive officer now owns 230,072 shares of the company’s stock, valued at $5,749,499.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Les B. Korsh sold 2,842 shares of the company’s stock in a transaction on Wednesday, July 3rd. The stock was sold at an average price of $23.71, for a total transaction of $67,383.82. Following the transaction, the insider now directly owns 103,765 shares in the company, valued at $2,460,268.15. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,149 shares of company stock valued at $415,851. Company insiders own 1.50% of the company’s stock.

Patterson Companies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 2nd. Shareholders of record on Friday, July 19th were paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 4.62%. The ex-dividend date of this dividend was Friday, July 19th. Patterson Companies’s dividend payout ratio is presently 52.00%.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.